Science Today |

Eye drops to reverse cataracts

UC San Francisco’s Jason Gestwicki describes his lab’s work developing eye drops to reverse cataracts, a potential boon to millions of people who go blind every year in developing countries because they can't afford (or have access to) the current, successful surgical treatment.

San Francisco Chronicle |

UCSF links key dementia protein, brain traumas

Prions, long studied by UCSF professor and Nobel laureate Stanley Prusiner, build up in the brain to cause Alzheimer's and other dementias. Now they're linked to post-traumatic stress disorder in combat veterans and in the brain damage of athletes who have suffered repeated concussions.
UC Office of the President |

UC researchers win new Breakthrough Prize

Napoleone Ferrara of UC San Diego and Shinya Yamanaka of the UCSF Gladstone Institutes among inaugural recipients.
UC San Francisco |

Hepatitis: UCSF and San Francisco at ground zero

San Francisco is a clinical hot spot for viral hepatitis infection, and UCSF is at the forefront in research, public health programs and clinical trials to fight back.
UC SF Public Affairs |

Students vaccinate against hepatitis B

The San Francisco Hepatitis B Collaborative offers free screenings for Hepatitis B (Hep B) and low cost vaccinations for community members every other Saturday at the Chinatown Public Health Clinic.